| Literature DB >> 35475136 |
A W Silagy1, R Young1, B D Kelly1, F Reeves2, M Furrer1,3, A J Costello1,4, B J Challacombe5, N M Corcoran1,4, J Kearsley1,4, P Dundee1,6,4, D K Agarwal1,6,4.
Abstract
Objective: To evaluate local clinical outcomes of sliding clip renorrhaphy, from inception to current utilization for open, laparoscopic, and robotically assisted partial nephrectomy.Entities:
Keywords: complications; partial nephrectomy; renorrhaphy; surgical history; surgical techniques
Year: 2021 PMID: 35475136 PMCID: PMC8988750 DOI: 10.1002/bco2.78
Source DB: PubMed Journal: BJUI Compass ISSN: 2688-4526
FIGURE 1Illustrated steps of the Agarwal Sliding‐Clip Technique. (A) The collecting system and deep layer is closed with a running 3‐0 monocryl (Ethicon Inc., Bridgewater, NJ, USA) or V‐Loc suture (Medtronic, Minneapolis, MN, USA). (B) A double arm suture is prepared with a gold hem‐o‐lok clip (Teleflex Medical, Research Triangle Park, NC, USA) using 0 vicryl suture (Ethicon Inc., Bridgewater, NJ, USA). (C) The superficial layer is closed with 2–3 double arm sutures placed 1 cm apart. Hem‐o‐lok clips are applied and slid down over the vicryl suture to compress the parenchyma achieving hemostasis. Hilar clamps are removed. (D) Additional hem‐o‐lok clips are applied with a locking end to secure the clips (E) If there is any oozing from the wound, the renal defect is filled with loose SURGICEL (Ethicon Inc., Bridgewater, NJ, USA) and Floseal (Baxter Healthcare Corporation, Freemont, CA, USA) and the suture ends are tied across
(A) Perioperative characteristics by surgical approach; (B) 90‐day postoperative complications
| Open (n = 15) | Laparoscopic (n = 48) | Robotic (n = 13) |
| |
|---|---|---|---|---|
|
| ||||
| Age (median [IQR]) | 56.00 [45.00, 60.50] | 56.00 [50.50, 65.00] | 56.00 [50.75, 64.25] | .75 |
| LOS (days) (median [IQR]) | 6.00 [4.00, 7.50] | 3.00 [2.00, 4.00] | 4.00 [3.00, 4.00] | <.001 |
| Operation time (median [IQR]) | 160.00 [102.00, 209.00] | 205.00 [156.50, 240.00] | 210.00 [200.00, 240.00] | .162 |
| Ischamia time (median [IQR]) | 0.00 [0.00, 14.25] | 21.00 [15.75, 32.00] | 20.00 [15.00, 24.00] | <.001 |
| Pre‐op eGFR (median [IQR]) | 74.00 [53.50, >90.00] | 83.00 [71.00, >90.00] | >90.00 [85.00, >90.00] | .277 |
| D1 post‐op eGFR (median [IQR]) | 50.00 [32.50, 89.00] | 65.00 [55.50, >90.00] | 83.00 [66.25, >90.00] | .161 |
| Change eGFR (median [IQR]) | 4.00 [0.00, 29.00] | 9.00 [0.00, 17.00] | 1.50 [0.00, 12.50] | .706 |
| Transfusion (%) | 3 (20.0) | 2 (4.2) | 2 (15.4) | .076 |
| RENAL nephrometry score (median [IQR]) | 7.00 [7.00, 8.75] | 6.00 [5.00, 7.00] | 7.00 [4.00, 9.00] | .242 |
| Surgical complexity (%) | .079 | |||
| High | 2 (20.0) | 0 (0.0) | 1 (7.7) | |
| Intermediate | 6 (60.0) | 10 (40.0) | 6 (46.2) | |
| Low | 2 (20.0) | 15 (60.0) | 6 (46.2) | |
| Tumor size (mm) (median [IQR]) | 28.00 [17.50, 33.50] | 23.00 [17.00, 30.00] | 25.00 [20.00, 46.00] | .174 |
| Pathology (%) | .013 | |||
| AML | 0 (0.0) | 2 (4.2) | 1 (7.7) | |
| Chromophobe RCC | 3 (20.0) | 3 (6.2) | 0 (0.0) | |
| Clear cell RCC | 12 (80.0) | 35 (72.9) | 5 (38.5) | |
| Oncocytoma | 0 (0.0) | 0 (0.0) | 2 (15.4) | |
| Papillary RCC | 0 (0.0) | 5 (10.4) | 4 (30.8) | |
| Unclassified RCC | 0 (0.0) | 3 (6.2) | 1 (7.7) | |
| T Stage (%) (Malignant tumors) | .003 | |||
| T1a | 11 (73.3) | 43 (93.5) | 5 (55.6) | |
| T1b | 3 (20.0) | 1 (2.2) | 4 (44.4) | |
| T3a | 1 (6.7) | 2 (4.3) | 0 (0.0) | |
| Positive margin (%) | 0 (0) | 1 (2.1) | 0 (0.0) | 1.000 |
|
| ||||
| Clavien‐Dindo Grade (%) | .009 | |||
| 0 | 3 (20.0) | 33 (68.8) | 9 (69.2) | |
| I | 5 (33.3) | 8 (16.7) | 1 (7.7) | |
| II | 5 (33.3) | 5 (10.4) | 1 (7.7) | |
| IIIa | 0 (0.0) | 1 (2.1) | 1 (7.7) | |
| Pseudoaneurysm requiring embolization | Iatrogenic pneumothorax. Intercostal catheter inserted on the ward | |||
| IIIb | 1 (6.7) | 1 (2.1) | 1 (7.7) | |
| Iatrogenic pneumothorax. Intercostal catheter inserted intraoperatively | Port site hernia, small bowel obstruction | Day 1 Bleed requiring embolization | ||
| IVa | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| IVb | 1 (6.7) | 0 (0.0) | 0 (0.0) | |
| Bleed requiring surgery & ICU admission for acidosis | ||||
| V | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Any‐Clavien‐Dindo grade (%) | 12 (80.0) | 15 (31.2) | 4 (30.8) | .003 |
| Clavien‐Dindo grade ≥3 (%) | 2 (13.3) | 2 (4.2) | 2 (15.4) | .188 |
Abbreviations: D1, day one; LOS, length of stay.
FIGURE 2Features associated with any‐grade complications. Age is measured at the time of surgery. Any Clavien‐Dindo complication (Grade ≥ 1) within 90 days of surgery is included